For decades, the standard treatment for these potentially ... benralizumab could become the first new therapy approved for eosinophilic exacerbations of asthma and COPD in over 50 years.

The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...

the world's most prescribed COPD treatment - with the long-acting beta agonist olodaterol. Spiriva will be facing generic competition in Europe and the US in the next few years, and the new ...

Although there isn’t currently a cure, you can find ways ... in Lebanon, New Hampshire. So what helps one person manage their ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual condition management.

Although there is no cure for COPD and new drugs still need to be developed, current treatment options such as statins may still benefit more patients if caregivers become more aware of their ...

New Study Shows Promising Results for COPD Treatment Nov. 20, 2024 — A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave ...

If you're not paying close attention, the first stage can be easy to miss. COPD treatment goal is to help you breathe easier and help regular activities. Medications along with lifestyle ...

GlaxoSmithKline's new treatment for COPD Anoro has received a positive opinion from the European regulator's CHMP committee. GSK has twinned its long-acting muscarinic antagonist (LAMA ...

People with COPD have a higher risk of developing pneumonia due to changes in their lung microbiome. Early detection and treatment could help reduce the risk of complications. Chronic obstructive ...

While there isn’t a cure for COPD, you can manage the condition and prevent it from materializing into severe symptoms. Managing COPD can also help reduce your risk for other conditions ...

2024 Dupilumab Earns FDA Priority Review for Add-On COPD Care The first new COPD treatment in a decade showed safety and effectiveness in a subset of patients with type 2 inflammation. Medscape ...